HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Guo-Ping Shi Selected Research

cathepsin S

10/2013Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction.
12/2012Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
1/2012Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study.
10/2007Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury.
11/2006Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure.
6/2006Increased serum cathepsin S in patients with atherosclerosis and diabetes.
3/2006Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors.
8/2004Lysosomal cysteine proteases in atherosclerosis.
1/2004Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries.
3/2003Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Guo-Ping Shi Research Topics

Disease

29Atherosclerosis
07/2015 - 03/2003
24Abdominal Aortic Aneurysm
01/2016 - 02/2006
13Inflammation
01/2016 - 02/2006
8Obesity
12/2015 - 12/2008
6Body Weight (Weight, Body)
12/2015 - 08/2007
6Myocardial Infarction
10/2014 - 06/2006
6Cardiovascular Diseases (Cardiovascular Disease)
02/2013 - 09/2005
5Fibrosis (Cirrhosis)
06/2015 - 08/2008
5Atherosclerotic Plaque (Atheroma)
12/2014 - 02/2005
4Heart Failure
10/2014 - 11/2006
4Vascular Diseases (Vascular Disease)
09/2011 - 02/2006
4Aneurysm (Aneurysms)
02/2011 - 11/2006
3Cardiomegaly (Heart Hypertrophy)
06/2015 - 02/2013
3Neoplasms (Cancer)
01/2015 - 03/2006
3Anoxia (Hypoxia)
01/2014 - 07/2010
3Hypertrophy
06/2013 - 11/2006
3Glucose Intolerance
02/2013 - 08/2007
3Pathologic Constriction (Stenosis)
11/2011 - 02/2006
3Unstable Angina
09/2011 - 06/2006
3Hypertension (High Blood Pressure)
01/2011 - 11/2006
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2014 - 01/2012
2Myocarditis (Carditis)
10/2014 - 01/2012
2Reperfusion Injury
10/2014 - 01/2012
2Metabolic Diseases (Metabolic Disease)
01/2013 - 12/2011
2Disease Progression
12/2012 - 01/2010
2Diabetes Mellitus
01/2012 - 01/2011
2Coronary Stenosis (Coronary Artery Stenosis)
11/2011 - 02/2006
2Angina Pectoris
04/2011 - 02/2009
2Coronary Disease (Coronary Heart Disease)
04/2011 - 02/2009
1Pneumonia (Pneumonitis)
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2015
1Renal Cell Carcinoma (Grawitz Tumor)
01/2015
1Nausea
01/2015
1Hematoma
01/2015
1Ventricular Remodeling
10/2014
1Weight Loss (Weight Reduction)
08/2014

Drug/Important Bio-Agent (IBA)

17Cysteine Proteases (Cysteine Protease)IBA
06/2015 - 01/2004
17CathepsinsIBA
02/2014 - 01/2004
10Glucose (Dextrose)FDA LinkGeneric
11/2015 - 06/2006
10Peptide Hydrolases (Proteases)IBA
02/2014 - 01/2004
10Cystatin CIBA
02/2014 - 03/2003
10cathepsin SIBA
10/2013 - 03/2003
9Cathepsin KIBA
06/2015 - 03/2007
8Angiotensin IIIBA
01/2016 - 03/2010
8ApolipoproteinsIBA
07/2015 - 02/2005
8Apolipoproteins E (ApoE)IBA
07/2015 - 02/2005
8LDL Receptors (LDL Receptor)IBA
11/2014 - 03/2003
7ElastinIBA
12/2015 - 01/2004
7Insulin (Novolin)FDA Link
11/2015 - 03/2006
7CytokinesIBA
05/2015 - 02/2006
7Tryptases (Tryptase)IBA
01/2013 - 01/2011
6Immunoglobulin E (IgE)IBA
01/2016 - 01/2011
6Chymases (Chymase)IBA
01/2013 - 09/2009
5Cathepsin LIBA
11/2011 - 02/2006
4CollagenIBA
12/2015 - 04/2007
4Protease Inhibitors (Protease Inhibitor)IBA
01/2013 - 02/2005
4Pancreatic Elastase (Elastase)IBA
01/2012 - 11/2007
3Serine Proteases (Serine Protease)IBA
12/2015 - 08/2004
3CholesterolIBA
11/2014 - 03/2003
3InterleukinsIBA
10/2014 - 06/2007
3Interleukin-17 (Interleukin 27)IBA
10/2014 - 06/2009
3Type 1 Angiotensin ReceptorIBA
01/2013 - 07/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2010 - 03/2006
3Interleukin-6 (Interleukin 6)IBA
08/2009 - 06/2007
2Cathepsin GIBA
12/2015 - 11/2014
2Carbon MonoxideIBA
07/2015 - 02/2014
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2014 - 12/2008
2Protein Kinases (Protein Kinase)IBA
10/2014 - 01/2013
2Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric
08/2013 - 11/2011
2Matrix MetalloproteinasesIBA
01/2013 - 08/2004
2ChemokinesIBA
12/2012 - 08/2009
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
11/2011 - 07/2006
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
03/2010 - 02/2009
2Complement System Proteins (Complement)IBA
03/2010 - 02/2009
2olmesartanIBA
07/2009 - 08/2008
2Fibronectins (Fibronectin)IBA
12/2008 - 08/2007
2Messenger RNA (mRNA)IBA
11/2006 - 01/2004
1Interleukin-13IBA
01/2016
1OvalbuminIBA
01/2016
1Interleukin-5 (Interleukin 5)IBA
01/2016
1anti-IgEIBA
01/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016
1LeptinIBA
12/2015
1Angiotensin IIBA
12/2015
1Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric
12/2015
1mitochondrial uncoupling protein (thermogenin)IBA
11/2015
1CCAAT-Enhancer-Binding ProteinsIBA
11/2015
1JNK Mitogen-Activated Protein KinasesIBA
11/2015
1Interleukin-18 (Interleukin 18)IBA
07/2015
1Interleukin-18 ReceptorsIBA
07/2015
1aliskirenFDA Link
12/2014
1ReninIBA
12/2014
1LDL CholesterolIBA
11/2014
1Lipoproteins (Lipoprotein)IBA
11/2014
1HDL CholesterolIBA
11/2014
1Triglycerides (Triacylglycerol)IBA
11/2014
1Blood Glucose (Blood Sugar)IBA
08/2014

Therapy/Procedure

1Local Anesthesia
01/2015
1Conscious Sedation
01/2015
1Cryosurgery
01/2015